carcinoembryonic antigen การใช้

• Examples are alphafetoprotein ( AFP ) and carcinoembryonic antigen ( CEA ).
• Carcinoembryonic antigen ( CEA ) is a marker found in several forms of cancer.
• Such tumor markers are, for instance, CEA ( carcinoembryonic antigen ) and AFP ( alpha fetoprotein ).
• This gene encodes a member of the carcinoembryonic antigen ( CEA ) gene family, which belongs to the immunoglobulin superfamily.
• These genes belong to a specific gene family; they are a subgroup of the carcinoembryonic antigen ( CEA ) family of genes.
• Immunohistochemical stain that can distinguish malignant from benign biliary ductal tissue, although staining for cytokeratins, carcinoembryonic antigen, and mucins may aid in diagnosis.
• The first winner of the Principal Award in 1982 was Phil Gold for his discovery of carcinoembryonic antigen, now widely used for cancer blood testing.
• Carcinoembryonic antigen blood level measurements follow the same timing, but are only advised for people with T2 or greater lesions who are candidates for intervention.
• Worldwide sales of the current leading test _ the carcinoembryonic antigen assay, or CEA _ are estimated by Matritech to exceed $ 100 million annually.
• This imaging technique is an improvement over initial efforts to engineer a Measles virus to carry the soluble marker human carcinoembryonic antigen ( CEA ).
• In 1965, he co-discovered with Phil Gold the carcinoembryonic antigen, the basis of a blood test used in the diagnosis and management of people with colorectal cancer.
• Cholangiocarcinoma can be detected with these commonly used tumor markers : carbohydrate antigen 19-9 ( CA 19-9 ), carcinoembryonic antigen ( CEA ) and cancer antigen 125 ( CA125 ).
• In 1968, he co-discovered with Samuel O . Freedman the carcinoembryonic antigen ( CEA ), which resulted in a blood test used in the diagnosis and management of people with cancer.
• A blood test for CEA ( carcinoembryonic antigen ) can sometimes pick up a recurrence, but 30 percent of these cancers do not produce CEA and the test misses some that do.
• There are newer non-invasive urine bound markers available as aids in the diagnosis of bladder cancer, including human complement factor H-related protein, high-molecular-weight carcinoembryonic antigen, and nuclear matrix protein 22 ( NMP22 ).
• The prognostic value of measuring calcitonin and carcinoembryonic antigen ( CEA ) concentrations in the blood was studied in 65 MTC patients who had abnormal calcitonin levels after surgery ( total thyroidectomy and lymph node dissection ).
• Immunostaining for most of the usual testicular germ cell tumour markers is negative ( " i . e . placental alkaline phosphatase ( PLAP ), vimentin, actin, desmin, alpha fetoprotein ( AFP ), OCT4, human chorionic gonadotropin ( hCG ), and carcinoembryonic antigen ( CEA ) ).